{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:26:50Z","timestamp":1795040810379,"version":"4.10.2"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC101-3114-Y-002-003"],"award-info":[{"award-number":["NSC101-3114-Y-002-003"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To investigate the risk of treatment-resistant depression (TRD) in patients with depression by examining their clinical features, early prescription patterns, and early and lifetime comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In total, 31,422 depressive inpatients were followed-up from diagnostic onset for more than 10-years. Patients were diagnosed with TRD if their antidepressant treatment regimen was altered \u2265two times or if they were admitted after at least two different antidepressant treatments. Multiple Cox regression model were used to determine whether physical and psychiatric comorbidities, psychosis, and prescription patterns increased the risk of TRD by controlling for relevant demographic covariates. Survival analyses were performed for important TRD-associated clinical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Females with depression (21.24%) were more likely to suffer from TRD than males (14.02%). Early anxiety disorders were more commonly observed in the TRD group than in the non-TRD group (81.48 vs. 58.96%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Lifetime anxiety disorders had the highest population attributable fraction (42.87%). Seventy percent of patients with multiple psychiatric comorbidities developed TRD during follow-up. Cox regression analysis further identified that functional gastrointestinal disorders significantly increased TRD risk (aHR\u2009=\u20091.19). Higher doses of antidepressants and benzodiazepines and Z drugs in the early course of major depressive disorder increased TRD risk (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicate the need to monitor early comorbidities and polypharmacy patterns in patients with depression associated with elevated TRD risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-020-02935-z","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T12:20:42Z","timestamp":1605615642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Shiau-Shian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-3587","authenticated-orcid":false,"given":"Po-Hsiu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"2935_CR1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1741-7015-9-90","volume":"9","author":"E Bromet","year":"2011","unstructured":"Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90.","journal-title":"BMC Med"},{"issue":"1","key":"2935_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/ern.09.137","volume":"10","author":"T Bschor","year":"2010","unstructured":"Bschor T. Therapy-resistant depression. Expert Rev Neurother. 2010;10(1):77\u201386.","journal-title":"Expert Rev Neurother"},{"issue":"9995","key":"2935_CR3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"T Vos","year":"2015","unstructured":"Vos T, Barber R, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, Charlson F. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743\u2013800.","journal-title":"Lancet."},{"key":"2935_CR4","volume-title":"Committee for Medicinal Product for Human Use (CHMP)","author":"Agency (EMEA) EM","year":"2009","unstructured":"Agency (EMEA) EM. Concept Paper on the Need for Revision of Note for Guidance on Clinical Investigation of Medicinal Products in the Treatment of Depression with regard to Treatment Resistant Depression. In: Committee for Medicinal Product for Human Use (CHMP); 2009."},{"issue":"11","key":"2935_CR5","first-page":"1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. AJ Psychiatry. 2006;163(11):1905\u201317.","journal-title":"AJ Psychiatry."},{"issue":"7","key":"2935_CR6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","volume":"68","author":"D Souery","year":"2007","unstructured":"Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 2007;68(7):1062\u201370.","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"2935_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.bp.110.086983","volume":"200","author":"CT Li","year":"2012","unstructured":"Li CT, Bai YM, Huang YL, Chen YS, Chen TJ, Cheng JY, Su TP. Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study. Br J Psychiatry. 2012;200(1):45\u201351.","journal-title":"Br J Psychiatry"},{"issue":"Suppl 8","key":"2935_CR8","first-page":"17","volume":"68","author":"CB Nemeroff","year":"2007","unstructured":"Nemeroff CB. Prevalence and management of treatment-resistant depression. J Clin Psychiatry. 2007;68(Suppl 8):17\u201325.","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"2935_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/acps.12959","volume":"139","author":"A Kautzky","year":"2019","unstructured":"Kautzky A, Dold M, Bartova L, Spies M, Kranz GS, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, et al. Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study. Acta Psychiatr Scand. 2019;139(1):78\u201388.","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"2935_CR10","first-page":"1286","volume":"160","author":"PB Peele","year":"2003","unstructured":"Peele PB, Xu Y, Kupfer DJ. Insurance expenditures on bipolar disorder: clinical and parity implications. AJ Psychiatry. 2003;160(7):1286\u201390.","journal-title":"AJ Psychiatry"},{"key":"2935_CR11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2014.10.059","volume":"173","author":"S Kohler","year":"2015","unstructured":"Kohler S, Wiethoff K, Ricken R, Stamm T, Baghai TC, Fisher R, Seemuller F, Brieger P, Cordes J, Malevani J, et al. Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disorders. J Affect Disord. 2015;173:126\u201333.","journal-title":"J Affect Disord"},{"issue":"1\u20132","key":"2935_CR12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jad.2010.03.001","volume":"126","author":"D Dudek","year":"2010","unstructured":"Dudek D, Rybakowski JK, Siwek M, Pawlowski T, Lojko D, Roczen R, Kiejna A. Risk factors of treatment resistance in major depression: association with bipolarity. J Affect Disord. 2010;126(1\u20132):268\u201371.","journal-title":"J Affect Disord"},{"issue":"9","key":"2935_CR13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071964","volume":"8","author":"M Takahashi","year":"2013","unstructured":"Takahashi M, Shirayama Y, Muneoka K, Suzuki M, Sato K, Hashimoto K. Low openness on the revised NEO personality inventory as a risk factor for treatment-resistant depression. PLoS One. 2013;8(9):e71964.","journal-title":"PLoS One"},{"issue":"5","key":"2935_CR14","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.4088\/JCP.14m09531","volume":"77","author":"A Krivoy","year":"2016","unstructured":"Krivoy A, Balicer RD, Feldman B, Hoshen M, Zalsman G, Weizman A, Shoval G. Adherence to antidepressants is associated with lower mortality: a 4-year population-based cohort study. J Clin Psychiatry. 2016;77(5):e566\u201372.","journal-title":"J Clin Psychiatry."},{"issue":"9","key":"2935_CR15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1507\/endocrj.EJ18-0579","volume":"66","author":"A Simayi","year":"2019","unstructured":"Simayi A, Mohemaiti P. Risk and protective factors of co-morbid depression in patients with type 2 diabetes mellitus: a meta analysis. Endocr J. 2019;66(9):793\u2013805.","journal-title":"Endocr J"},{"key":"2935_CR16","doi-asserted-by":"crossref","first-page":"100822","DOI":"10.1016\/j.pmedr.2019.100822","volume":"14","author":"B Chireh","year":"2019","unstructured":"Chireh B, Li M, D'Arcy C. Diabetes increases the risk of depression: a systematic review, meta-analysis and estimates of population attributable fractions based on prospective studies. Prev Med Rep. 2019;14:100822.","journal-title":"Prev Med Rep"},{"issue":"6","key":"2935_CR17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PSY.0000000000000074","volume":"76","author":"LV Doering","year":"2014","unstructured":"Doering LV, Chen B, McGuire A, Bodan RC, Irwin MR. Persistent depressive symptoms and pain after cardiac surgery. Psychosom Med. 2014;76(6):437\u201344.","journal-title":"Psychosom Med"},{"issue":"6","key":"2935_CR18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/JCP.0000000000000599","volume":"36","author":"R Lewis-Fernandez","year":"2016","unstructured":"Lewis-Fernandez R, Lam P, Lucak S, Galfalvy H, Jackson E, Fried J, Rosario M, de la Cruz AA, Sanchez-Lacay A, Diaz S, et al. An open-label pilot study of duloxetine in patients with irritable bowel syndrome and comorbid major depressive disorder. J Clin Psychopharmacol. 2016;36(6):710\u20135.","journal-title":"J Clin Psychopharmacol"},{"key":"2935_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/590648","volume":"2012","author":"MP Hage","year":"2012","unstructured":"Hage MP, Azar ST. The link between thyroid function and depression. J Thyroid Res. 2012;2012:1\u20138.","journal-title":"J Thyroid Res"},{"issue":"5","key":"2935_CR20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0961203313477227","volume":"22","author":"LP MM","year":"2013","unstructured":"MM LP, Tani C, Gemignani A, Mauri M, Bombardieri S. Depression and systemic lupus erythematosus: a systematic review. Lupus. 2013;22(5):409\u201316.","journal-title":"Lupus."},{"issue":"2","key":"2935_CR21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S2215-0366(18)30255-4","volume":"6","author":"L Nerurkar","year":"2019","unstructured":"Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry. 2019;6(2):164\u201373.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"2935_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jad.2005.03.005","volume":"87","author":"AJ Rush","year":"2005","unstructured":"Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, Biggs MM, Shores-Wilson K, Shelton RC, Luther JF, et al. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J Affect Disord. 2005;87(1):43\u201355.","journal-title":"J Affect Disord"},{"issue":"6","key":"2935_CR23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2935_CR24","volume":"15","author":"M Asp","year":"2020","unstructured":"Asp M, Lindqvist D, Fernstrom J, Ambrus L, Tuninger E, Reis M, Westrin A. Recognition of personality disorder and anxiety disorder comorbidity in patients treated for depression in secondary psychiatric care. PLoS One. 2020;15(1):e0227364.","journal-title":"PLoS One"},{"issue":"7","key":"2935_CR25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/da.22774","volume":"35","author":"MS Cepeda","year":"2018","unstructured":"Cepeda MS, Reps J, Ryan P. Finding factors that predict treatment-resistant depression: results of a cohort study. Depress Anxiety. 2018;35(7):668\u201373.","journal-title":"Depress Anxiety."},{"issue":"4","key":"2935_CR26","doi-asserted-by":"crossref","first-page":"e0215289","DOI":"10.1371\/journal.pone.0215289","volume":"14","author":"B Kollhorst","year":"2019","unstructured":"Kollhorst B, Jobski K, Krappweis J, Schink T, Garbe E, Schmedt N. Antidepressants and the risk of death in older patients with depression: a population-based cohort study. PLoS One. 2019;14(4):e0215289.","journal-title":"PLoS One"},{"issue":"11","key":"2935_CR27","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1016\/j.ridd.2013.08.035","volume":"34","author":"CS Wu","year":"2013","unstructured":"Wu CS, Desarkar P, Palucka A, Lunsky Y, Liu SK. Acute inpatient treatment, hospitalization course and direct costs in bipolar patients with intellectual disability. Res Dev Disabil. 2013;34(11):4062\u201372.","journal-title":"Res Dev Disabil"},{"issue":"7","key":"2935_CR28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4088\/JCP.v64n0714","volume":"64","author":"MA Oquendo","year":"2003","unstructured":"Oquendo MA, Baca-Garcia E, Kartachov A, Khait V, Campbell CE, Richards M, Sackeim HA, Prudic J, Mann JJ. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. J Clin Psychiatry. 2003;64(7):825\u201333.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"2935_CR29","doi-asserted-by":"crossref","first-page":"e010802","DOI":"10.1136\/bmjopen-2015-010802","volume":"6","author":"CL Chiang","year":"2016","unstructured":"Chiang CL, Chen PC, Huang LY, Kuo PH, Tung YC, Liu CC, Chen WJ. Impact of universal health coverage on urban-rural inequity in psychiatric service utilisation for patients with first admission for psychosis: a 10-year nationwide population-based study in Taiwan. BMJ Open. 2016;6(3):e010802.","journal-title":"BMJ Open"},{"key":"2935_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","volume":"156","author":"RS McIntyre","year":"2014","unstructured":"McIntyre RS, Filteau MJ, Martin L, Patry S, Carvalho A, Cha DS, Barakat M, Miguelez M. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1\u20137.","journal-title":"J Affect Disord"},{"issue":"3","key":"2935_CR31","first-page":"531","volume":"9","author":"ML Levin","year":"1953","unstructured":"Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9(3):531\u201341.","journal-title":"Acta Unio Int Contra Cancrum"},{"issue":"2","key":"2935_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4088\/JCP.08m04309","volume":"70","author":"A Fekadu","year":"2009","unstructured":"Fekadu A, Wooderson S, Donaldson C, Markopoulou K, Masterson B, Poon L, Cleare AJ. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J Clin Psychiatry. 2009;70(2):177\u201384.","journal-title":"J Clin Psychiatry."},{"issue":"10","key":"2935_CR33","doi-asserted-by":"crossref","first-page":"e76882","DOI":"10.1371\/journal.pone.0076882","volume":"8","author":"N Kubitz","year":"2013","unstructured":"Kubitz N, Mehra M, Potluri RC, Garg N, Cossrow N. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database. PLoS One. 2013;8(10):e76882.","journal-title":"PLoS One"},{"issue":"617","key":"2935_CR34","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.3399\/bjgp13X675430","volume":"63","author":"L Thomas","year":"2013","unstructured":"Thomas L, Kessler D, Campbell J, Morrison J, Peters TJ, Williams C, Lewis G, Wiles N. Prevalence of treatment-resistant depression in primary care: cross-sectional data. Br J Gen Pract. 2013;63(617):e852\u20138.","journal-title":"Br J Gen Pract"},{"issue":"10164","key":"2935_CR35","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/S0140-6736(18)33124-6","volume":"392","author":"J Van Zundert","year":"2018","unstructured":"Van Zundert J, Hans G, van Kuijk S, Van Boxem K, Vissers K. Low back pain. Lancet. 2018;392(10164):2548\u20139.","journal-title":"Lancet."},{"issue":"10137","key":"2935_CR36","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(18)30725-6","volume":"391","author":"S Clark","year":"2018","unstructured":"Clark S, Horton R. Low back pain: a major global challenge. Lancet. 2018;391(10137):2302.","journal-title":"Lancet."},{"issue":"2","key":"2935_CR37","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JOE-13-0588","volume":"221","author":"RS Fortunato","year":"2014","unstructured":"Fortunato RS, Ferreira AC, Hecht F, Dupuy C, Carvalho DP. Sexual dimorphism and thyroid dysfunction: a matter of oxidative stress? J Endocrinol. 2014;221(2):R31\u201340.","journal-title":"J Endocrinol"},{"issue":"2","key":"2935_CR38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12640-017-9835-5","volume":"33","author":"M Sowa-Kucma","year":"2018","unstructured":"Sowa-Kucma M, Styczen K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G, Maes M. Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia. Neurotox Res. 2018;33(2):448\u201360.","journal-title":"Neurotox Res"},{"issue":"1","key":"2935_CR39","first-page":"7","volume":"32","author":"M Maes","year":"2011","unstructured":"Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression's multiple comorbidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways. Neuro endocrinology letters. 2011;32(1):7\u201324.","journal-title":"Neuro endocrinology letters"},{"issue":"7","key":"2935_CR40","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1053\/j.gastro.2009.04.032","volume":"136","author":"Y Tache","year":"2009","unstructured":"Tache Y, Bernstein CN. Evidence for the role of the brain-gut axis in inflammatory bowel disease: depression as cause and effect? Gastroenterology. 2009;136(7):2058\u201361.","journal-title":"Gastroenterology."},{"key":"2935_CR41","first-page":"CD003460","volume":"8","author":"L Ruepert","year":"2011","unstructured":"Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2011;8:CD003460.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2935_CR42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1550-8579(06)80192-0","volume":"3","author":"SK Ahlawat","year":"2006","unstructured":"Ahlawat SK, Cuddihy MT, Locke GR 3rd. Gender-related differences in dyspepsia: a qualitative systematic review. Gend Med. 2006;3(1):31\u201342.","journal-title":"Gend Med"},{"issue":"9","key":"2935_CR43","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/da.22233","volume":"31","author":"HM van Loo","year":"2014","unstructured":"van Loo HM, Cai T, Gruber MJ, Li J, de Jonge P, Petukhova M, Rose S, Sampson NA, Schoevers RA, Wardenaar KJ, et al. Major depressive disorder subtypes to predict long-term course. Depress Anxiety. 2014;31(9):765\u201377.","journal-title":"Depress Anxiety."},{"key":"2935_CR44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jad.2014.09.020","volume":"171","author":"D Bennabi","year":"2015","unstructured":"Bennabi D, Aouizerate B, El-Hage W, Doumy O, Moliere F, Courtet P, Nieto I, Bellivier F, Bubrovsky M, Vaiva G, et al. Risk factors for treatment resistance in unipolar depression: a systematic review. J Affect Disord. 2015;171:137\u201341.","journal-title":"J Affect Disord"},{"issue":"2","key":"2935_CR45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/da.1050","volume":"14","author":"EJ Lenze","year":"2001","unstructured":"Lenze EJ, Mulsant BH, Shear MK, Alexopoulos GS, Frank E, Reynolds CF 3rd. Comorbidity of depression and anxiety disorders in later life. Depress Anxiety. 2001;14(2):86\u201393.","journal-title":"Depress Anxiety"},{"issue":"1","key":"2935_CR46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11920-003-0011-7","volume":"5","author":"EJ Lenze","year":"2003","unstructured":"Lenze EJ. Comorbidity of depression and anxiety in the elderly. Curr Psychiatry Rep. 2003;5(1):62\u20137.","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"2935_CR47","first-page":"107","volume":"5","author":"AJ Flint","year":"1997","unstructured":"Flint AJ, Rifat SL. Anxious depression in elderly patients. Response to antidepressant treatment. Am J Geriatr Psychiatry. 1997;5(2):107\u201315.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"2935_CR48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/JCP.0b013e318217b4c4","volume":"31","author":"PN Pfeiffer","year":"2011","unstructured":"Pfeiffer PN, Ganoczy D, Zivin K, Valenstein M. Benzodiazepines and adequacy of initial antidepressant treatment for depression. J Clin Psychopharmacol. 2011;31(3):360\u20134.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"2935_CR49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0272-7358(99)00028-8","volume":"20","author":"TJ Trull","year":"2000","unstructured":"Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev. 2000;20(2):235\u201353.","journal-title":"Clin Psychol Rev"},{"issue":"8","key":"2935_CR50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","volume":"61","author":"BF Grant","year":"2004","unstructured":"Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(8):807\u201316.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2935_CR51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31887\/DCNS.2015.17.2\/btolliver","volume":"17","author":"BK Tolliver","year":"2015","unstructured":"Tolliver BK, Anton RF. Assessment and treatment of mood disorders in the context of substance abuse. Dialogues Clin Neurosci. 2015;17(2):181\u201390.","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"2935_CR52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp053113","volume":"3","author":"SB Quello","year":"2005","unstructured":"Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005;3(1):13\u201321.","journal-title":"Sci Pract Perspect"},{"key":"2935_CR53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12888-016-0790-0","volume":"16","author":"AM Boerema","year":"2016","unstructured":"Boerema AM, Kleiboer A, Beekman AT, van Zoonen K, Dijkshoorn H, Cuijpers P. Determinants of help-seeking behavior in depression: a cross-sectional study. BMC Psychiatry. 2016;16:78.","journal-title":"BMC Psychiatry"},{"key":"2935_CR54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1192\/bjp.154.2.201","volume":"154","author":"M Hamilton","year":"1989","unstructured":"Hamilton M. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry. 1989;154:201\u20136.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"2935_CR55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4088\/JCP.v64n0204","volume":"64","author":"GA Fava","year":"2003","unstructured":"Fava GA. Can long-term treatment with antidepressant drugs worsen the course of depression? J Clin Psychiatry. 2003;64(2):123\u201333.","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"2935_CR56","first-page":"93","volume":"76","author":"JD van Scheyen","year":"1973","unstructured":"van Scheyen JD. Recurrent vital depressions. A follow-up study of 56 female and 28 male patients. Psychiatr Neurol Neurochir. 1973;76(2):93\u2013112.","journal-title":"Psychiatr Neurol Neurochir"},{"issue":"11","key":"2935_CR57","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archpsyc.1991.01810350067011","volume":"48","author":"JJ Mann","year":"1991","unstructured":"Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry. 1991;48(11):1027\u201333.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2935_CR58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jad.2012.10.033","volume":"148","author":"RJ Baldessarini","year":"2013","unstructured":"Baldessarini RJ, Faedda GL, Offidani E, Vazquez GH, Marangoni C, Serra G, Tondo L. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord. 2013;148(1):129\u201335.","journal-title":"J Affect Disord"},{"issue":"5","key":"2935_CR59","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1440-1819.2011.02231.x","volume":"65","author":"G Katz","year":"2011","unstructured":"Katz G. Tachyphylaxis\/tolerance to antidepressants in treatment of dysthymia: results of a retrospective naturalistic chart review study. Psychiatry Clin Neurosci. 2011;65(5):499\u2013504.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"2935_CR60","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2174\/1570159X13666150630173522","volume":"13","author":"RT de Sousa","year":"2015","unstructured":"de Sousa RT, Zanetti MV, Brunoni AR, Machado-Vieira R. Challenging treatment-resistant major depressive disorder: a roadmap for improved therapeutics. Curr Neuropharmacol. 2015;13(5):616\u201335.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"2935_CR61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001403","volume":"10","author":"GI Spielmans","year":"2013","unstructured":"Spielmans GI, Berman MI, Linardatos E, Rosenlicht NZ, Perry A, Tsai AC. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013;10(3):e1001403.","journal-title":"PLoS Med"},{"key":"2935_CR62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jad.2014.05.053","volume":"168","author":"JC Nelson","year":"2014","unstructured":"Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression. J Affect Disord. 2014;168:269\u201375.","journal-title":"J Affect Disord"},{"key":"2935_CR63","doi-asserted-by":"crossref","first-page":"110041","DOI":"10.1016\/j.pnpbp.2020.110041","volume":"104","author":"Q Wang","year":"2021","unstructured":"Wang Q, Dwivedi Y. Advances in novel molecular targets for antidepressants. Prog Neuropsychopharmacol Bol Psychiatry. 2021;104:110041.","journal-title":"Prog Neuropsychopharmacol Bol Psychiatry"},{"key":"2935_CR64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2019.08.022","volume":"259","author":"MH Chen","year":"2019","unstructured":"Chen MH, Lin WC, Tu PC, Li CT, Bai YM, Tsai SJ, Su TP. Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: a double-blind, placebo-controlled, randomized, longitudinal resting fMRI study. J Affect Disord. 2019;259:15\u201320.","journal-title":"J Affect Disord"},{"issue":"13","key":"2935_CR65","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/npp.2017.94","volume":"42","author":"TP Su","year":"2017","unstructured":"Su TP, Chen MH, Li CT, Lin WC, Hong CJ, Gueorguieva R, Tu PC, Bai YM, Cheng CM, Krystal JH. Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression. Neuropsychopharmacology. 2017;42(13):2482\u201392.","journal-title":"Neuropsychopharmacology."},{"key":"2935_CR66","doi-asserted-by":"crossref","unstructured":"Chen MH, Lin WC, Wu HJ, Bai YM, Li CT, Tsai SJ, Hong CJ, Tu PC, Cheng CM, Su TP. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression. CNS Spectr. 2020:1\u20136.","DOI":"10.1017\/S1092852920001194"},{"issue":"2","key":"2935_CR67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1570159X17666190903103923","volume":"18","author":"SG Ferber","year":"2020","unstructured":"Ferber SG, Namdar D, Hen-Shoval D, Eger G, Koltai H, Shoval G, Shbiro L, Weller A. The \"entourage effect\": Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. Curr Neuropharmacol. 2020;18(2):87\u201396.","journal-title":"Curr Neuropharmacol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-020-02935-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T12:24:46Z","timestamp":1605615886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-020-02935-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2935"],"URL":"https:\/\/doi.org\/10.1186\/s12888-020-02935-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-31649\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-31649\/v2","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"28 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received ethical approval from the Institutional Review Board (IRB) of National Taiwan University (NTUH-REC-201303020RINC).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study uses unidentifiable data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"541"}}